These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2329563)

  • 21. [[omega-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents.
    Cantello BC; Cawthorne MA; Cottam GP; Duff PT; Haigh D; Hindley RM; Lister CA; Smith SA; Thurlby PL
    J Med Chem; 1994 Nov; 37(23):3977-85. PubMed ID: 7966158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and antidiabetic activity of novel 2,4-thiazolidinedione derivatives containing a thiazole ring.
    Bozdağ-Dündar O; Ceylan-Unlüsoy M; Verspohl EJ; Ertan R
    Arzneimittelforschung; 2006; 56(9):621-5. PubMed ID: 17063636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Troglitazone: antihyperglycemic activity and potential role in the treatment of type 2 diabetes.
    Scheen AJ; Lefèbvre PJ
    Diabetes Care; 1999 Sep; 22(9):1568-77. PubMed ID: 10480527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on antidiabetic agents. X. Synthesis and biological activities of pioglitazone and related compounds.
    Momose Y; Meguro K; Ikeda H; Hatanaka C; Oi S; Sohda T
    Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1440-5. PubMed ID: 1934164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The development of thiazolidinedione drugs as anti-diabetic agents].
    Kuzuya T
    Nihon Rinsho; 2000 Feb; 58(2):364-9. PubMed ID: 10707559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative.
    Shibata T; Matsui K; Nagao K; Shinkai H; Yonemori F; Wakitani K
    Eur J Pharmacol; 1999 Jan; 364(2-3):211-9. PubMed ID: 9932726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
    Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
    Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and structure-activity relationship studies of cinnamic acid-based novel thiazolidinedione antihyperglycemic agents.
    Neogi P; Lakner FJ; Medicherla S; Cheng J; Dey D; Gowri M; Nag B; Sharma SD; Pickford LB; Gross C
    Bioorg Med Chem; 2003 Sep; 11(18):4059-67. PubMed ID: 12927868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and hypoglycemic activity of some substituted flavonyl thiazolidinedione derivatives--fifth communication: flavonyl benzyl substituted 2,4-thiazolidinediones.
    Tunçbilek M; Bozdağ-Dündar O; Ayhan-Kilcigil G; Ceylan M; Waheed A; Verspohl EJ; Ertan R
    Farmaco; 2003 Jan; 58(1):79-83. PubMed ID: 12595040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel oximes having 5-benzyl-2,4-thiazolidinedione as antihyperglycemic agents: synthesis and structure-activity relationship.
    Yanagisawa H; Takamura M; Yamada E; Fujita S; Fujiwara T; Yachi M; Isobe A; Hagisawa Y
    Bioorg Med Chem Lett; 2000 Feb; 10(4):373-5. PubMed ID: 10714503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular design, synthesis, and hypoglycemic activity of a series of thiazolidine-2,4-diones.
    Oguchi M; Wada K; Honma H; Tanaka A; Kaneko T; Sakakibara S; Ohsumi J; Serizawa N; Fujiwara T; Horikoshi H; Fujita T
    J Med Chem; 2000 Aug; 43(16):3052-66. PubMed ID: 10956213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel antidiabetic and hypolipidemic agents. 3. Benzofuran-containing thiazolidinediones.
    Reddy KA; Lohray BB; Bhushan V; Bajji AC; Reddy KV; Reddy PR; Krishna TH; Rao IN; Jajoo HK; Rao NV; Chakrabarti R; Dileepkumar T; Rajagopalan R
    J Med Chem; 1999 Jun; 42(11):1927-40. PubMed ID: 10354401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and hypoglycemic activity of some new flavone derivatives. 2nd communication: 4'-flavonyl-2,4-thiazolidinediones.
    Bozdağ O; Verspohl EJ; Ertan R
    Arzneimittelforschung; 2000 Jun; 50(6):539-43. PubMed ID: 10918947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoglycemic activity of a series of alpha-alkylthio and alpha-alkoxy carboxylic acids related to ciglitazone.
    Hulin B; Newton LS; Lewis DM; Genereux PE; Gibbs EM; Clark DA
    J Med Chem; 1996 Sep; 39(20):3897-907. PubMed ID: 8831756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel euglycemic and hypolipidemic agents: Part-2. Antioxidant moiety as structural motif.
    Reddy KA; Lohray BB; Bhushan V; Reddy AS; Kishore PH; Rao VV; Saibaba V; Bajji AC; Rajesh BM; Reddy KV; Chakrabarti R; Rajagopalan R
    Bioorg Med Chem Lett; 1998 May; 8(9):999-1002. PubMed ID: 9871696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-alpha/gamma agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical models.
    Etgen GJ; Oldham BA; Johnson WT; Broderick CL; Montrose CR; Brozinick JT; Misener EA; Bean JS; Bensch WR; Brooks DA; Shuker AJ; Rito CJ; McCarthy JR; Ardecky RJ; Tyhonas JS; Dana SL; Bilakovics JM; Paterniti JR; Ogilvie KM; Liu S; Kauffman RF
    Diabetes; 2002 Apr; 51(4):1083-7. PubMed ID: 11916929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and antihyperglycemic evaluation of new 2,4-thiazolidinediones having biodynamic aryl sulfonylurea moieties.
    Jawale DV; Pratap UR; Rahuja N; Srivastava AK; Mane RA
    Bioorg Med Chem Lett; 2012 Jan; 22(1):436-9. PubMed ID: 22123321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vanadyl-thiazolidinedione combination agents for diabetes therapy.
    Storr T; Mitchell D; Buglyó P; Thompson KH; Yuen VG; McNeill JH; Orvig C
    Bioconjug Chem; 2003; 14(1):212-21. PubMed ID: 12526711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agent.
    Fujita T; Sugiyama Y; Taketomi S; Sohda T; Kawamatsu Y; Iwatsuka H; Suzuoki Z
    Diabetes; 1983 Sep; 32(9):804-10. PubMed ID: 6354788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihyperglycemic effect of a new thiazolidinedione analogue and its role in ameliorating oxidative stress in alloxan-induced diabetic rats.
    Chaudhry J; Ghosh NN; Roy K; Chandra R
    Life Sci; 2007 Feb; 80(12):1135-42. PubMed ID: 17234217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.